Home-measured heart rate is associated with albuminuria in patients with type 2 diabetes mellitus: A post-hoc analysis of a cross-sectional multicenter study

Hypertension Research

Volumn 37, Issue 6, 2014, Pages 533-537

  Ushigome, Emi ^a   Fukui, Michiaki ^a   Hamaguchi, Masahide ^b   Tanaka, Toru ^c   Atsuta, Haruhiko ^d   Ohnishi, Masayoshi ^e   Tsunoda, Sei ^f   Yamazaki, Masahiro ^a   Hasegawa, Goji ^a   Nakamura, Naoto ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^d KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^e WEST JAPAN RAILWAY COMPANY   (Japan)

^f Department of Cardiology Nishijin Hospital ^*  (Japan)

Author keywords

diabetic nephropathy; home measured heart rate; multicenter study

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALBUMINURIA; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; HEART RATE; HOME MONITORING; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POST HOC ANALYSIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION; AMBULATORY MONITORING; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMPLICATION; DIABETIC NEPHROPATHIES; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL;

AGED; ALBUMINURIA; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEART RATE; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 84901985094     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2014.42     Document Type: Article

References (31)

1. The effect of intensive treatment of diabetes on the development and progression oflong-term complications in insulin-dependent diabetes mellitus. The Diabetes Controland Complications Trial Research Group. New Engl J Med 1993; 329: 977-986.
2. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S HOPE Study Investigators. Albuminuria and riskof cardiovascular events, death, and heart failure in diabetic and nondiabeticindividuals. JAMA 2001; 286: 421-426.
3. Linnemann B, Janka HU. Prolonged QTc interval and elevated heart rate identify thetype 2 diabetic patient at high risk for cardiovascular death. The Bremen DiabetesStudy. Exp Clin Endocrinol Diabetes 2003; 111: 215-222.
4. Hozawa A, Ohkubo T, Kikuya M, Ugajin T, Yamaguchi J, Asayama K, Metoki H, Ohmori K, Hoshi H, Hashimoto J, Satoh H, Tsuji I, Imai Y. Prognostic value of homeheart rate for cardiovascular mortality in the general population: the Ohasama study.Am J Hypertens 2004; 17: 1005-1010.
5. Jouven X, Empana J-P, Schwartz PJ, Desnos M, Courbon D, Ducimetiè re P. Heart-rateprofile during exercise as a predictor of sudden death. New Engl J Med 2005; 352:1951-1958.
6. Palatini P, Benetos A, Grassi G, Julius S, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Pessina AC, Ruilope LM, Zanchetti A European Society of Hypertension.Identification and management of the hypertensive patient with elevated heart rate:statement of a European Society of Hypertension Consensus Meeting. J Hypertens2006; 24: 603-610.
7. Palatini P, Dorigatti F, Zaetta V, Mormino P, Mazzer A, Bortolazzi A, D'Este D, Pegoraro F, Milani L, Mos L HARVEST Study Group. Heart rate as a predictor ofdevelopment of sustained hypertension in subjects screened for stage 1 hypertension:the HARVEST study. J Hypertens 2006; 24: 1873-1880.
8. Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease.Clin Exp Hypertens 2004; 26: 637-644.
9. Lang CC, Gupta S, Kalra P, Keavney B, Menown I, Morley C, Padmanabhan S. Elevatedheart rate and cardiovascular outcomes in patients with coronary artery disease: clinicalevidence and pathophysiological mechanisms. Atherosclerosis 2010; 212: 1-8.
10. Ahdmai-Kashani M, Kessler DJ, Day J, Bunch TJ, Stolen KQ, Brown S, Sbaity S, Olshansky B INTRINSIC RV Study Investigators. Heart rate predicts outcomes in animplantable cardioverter-defibrillator population. Circulation 2009; 120: 2040-2045.
11. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M Heart Rate Working Group. Resting heart rate in cardiovasculardisease. J Am Coll Cardiol 2007; 50: 823-830.
12. Palatini P. Elevated heart rate in cardiovascular diseases: a target for treatment? ProgCardiovasc Dis 2009; 52: 46-60.
13. Hillis GS, Hata J, Woodward M, Perkovic V, Arima H, Chow CK, Zoungas S, Patel A, Poulter NR, Mancia G, Williams B, Chalmers J. Resting heart rate and the risk ofmicrovascular complications in patients with type 2 diabetes mellitus. J Am HeartAssoc 2012; 1: e002832.
14. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Kikuya M, Ito S, Satoh H, Hisamichi S. Home blood pressure measurementhas a stronger predictive power for mortality than does screening blood pressuremeasurement: a population-based observation in Ohasama, Japan. J Hypertens 1998;16: 971-975.
15. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM.Cardiovascular prognosis of 'masked hypertension' detected by blood pressureself-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
16. Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y Ohasama Study. How many times should blood pressure be measured at homefor better prediction of stroke risk? Ten-year follow-up results from the Ohasama study.J Hypertens 2004; 22: 1099-1104.
17. Parati G, Mancia G. Assessing the white-coat effect: which blood pressure measurementshould be considered? J Hypertens 2006; 24: 29-31.
18. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion J-M, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P European Society of Hypertension Working Group on BloodPressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
19. Imai Y, Kario K, Shimada K, Kawano Y, Hasebe N, Matsuura H, Tsuchihashi T, Ohkubo T, Kuwajima I, Miyakawa M Japanese Society of Hypertension Committee forGuidelines for Self-monitoring of Blood Pressure at Home. The Japanese Society ofHypertension Guidelines for Self-monitoring of Blood Pressure at Home (SecondEdition). Hypertens Res 2012; 35: 777-795.
20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report ofthe expert committee on the diagnosis and classification of diabetes mellitus. Diabetescare 2003; 26(Suppl 1), S5-20.
21. Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the BritishHypertension Society protocol. Blood Press Monit 2006; 11: 27-32.
22. Yasuda H, Sanada M, Kitada K, Terashima T, Kim H, Sakaue Y, Fujitani M, Kawai H, Maeda K, Kashiwagi A. Rationale and usefulness of newly devised abbreviateddiagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract2007; 77(Suppl 1), S178-S183.
23. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bombelli M, Giannattasio C, Zanchetti A, Mancia G. Alterations of cardiac structure inpatients with isolated office, ambulatory, or home hypertension: data from the generalpopulation (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study).Circulation 2001; 104: 1385-1392.
24. Bassiouny HS, Zarins CK, Lee DC, Skelly CL, Fortunato JE, Glagov S. Diurnal heart ratereactivity: a predictor of severity of experimental coronary and carotid atherosclerosis.J Cardiovasc Risk 2002; 9: 331-338.
25. Manuck SB, Adams MR, McCaffery JM, Kaplan JR. Behaviorally elicited heart ratereactivity and atherosclerosis in ovariectomized cynomolgus monkeys (Macaca fascicularis).Arterioscler Thromb Vasc Biol 1997; 17: 1774-1779.
26. Giannoglou GD, Chatzizisis YS, Zamboulis C, Parcharidis GE, Mikhailidis DP, Louridas GE. Elevated heart rate and atherosclerosis: an overview of the pathogeneticmechanisms. Int J Cardiol 2008; 126: 302-312.
27. Böhm M, Reil J-C, Danchin N, Thoenes M, Bramlage P, Volpe M. Association ofheart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH.J Hypertens 2008; 26: 18-25.
28. Flannery G, Gehrig-Mills R, Billah B, Krum H. Analysis of randomized controlled trialson the effect of magnitude of heart rate reduction on clinical outcomes in patientswith systolic chronic heart failure receiving beta-blockers. Am J Cardiol 2008; 101:865-869.
29. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L SHIFT Investigators. Ivabradine and outcomes in chronicheart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010; 376:875-885.
30. Menne J, Izzo Jr JL, Ito S, Januszewicz A, Katayama S, Chatzykirkou C, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, Haller H ROADMAPinvestigators. Prevention of microalbuminuria in patients with type 2 diabetes andhypertension. J Hypertens 2012; 30: 811-818.
31. Van der Hoeven NV, Van den Born B-JH, Cammenga M, Van Montfrans GA. Pooradherence to home blood pressure measurement schedule. J Hypertens 2009; 27:275-279.